EGFR c.3206A>T ;(p.Y1069F)

Variant ID: 7-55270253-A-T

NM_005228.3(EGFR):c.3206A>T;(p.Y1069F)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Nature Communications
Kis, Olena O; Kaedbey, Rayan R; Chow, Signy S; Danesh, Arnavaz A; Dowar, Mark M; Li, Tiantian T; Li, Zhihua Z; Liu, Jessica J; Mansour, Mark M; Masih-Khan, Esther E; Zhang, Tong T; Bratman, Scott V SV; Oza, Amit M AM; Kamel-Reid, Suzanne S; Trudel, Suzanne S; Pugh, Trevor J TJ
Publication Date: 2017-05-11

Variant appearance in text: ERBB: 3206A>T
PubMed Link: 28492226
Variant Present in the following documents:
  • ncomms15086-s3.xlsx, sheet 1
View BVdb publication page



Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.

Oncotarget
Kim, Nayoung N; Cho, Ahye A; Watanabe, Hideo H; Choi, Yoon-La YL; Aziz, Meraj M; Kassner, Michelle M; Joung, Je-Gun JG; Park, Angela Kyung-Joo AK; Francis, Joshua M JM; Bae, Joon Seol JS; Ahn, Soo-Min SM; Kim, Kyoung-Mee KM; Park, Joon Oh JO; Park, Woong-Yang WY; Ahn, Myung-Ju MJ; Park, Keunchil K; Koo, Jaehyung J; Yin, Hongwei Holly HH; Cho, Jeonghee J
Publication Date: 2016-03-22

Variant appearance in text: EGFR: Y1069F
PubMed Link: 26883194
Variant Present in the following documents:
  • Main text
  • oncotarget-07-13797.pdf
View BVdb publication page